Risks and limits of Abnehmspritze Senioren

The question about risks and limits of weight loss injections (GLP-1 agonists like semaglutide) in seniors is clinically relevant but not addressed in the provided context. Based on general medical knowledge: in older adults, there is increased risk of muscle loss (sarcopenia), malnutrition, dehydration, and drug interactions. Long-term safety data in frail seniors are limited. These injections are not a substitute for lifestyle changes. Evidence level: practice/clinical guidelines. Medical supervision is mandatory.